78 related articles for article (PubMed ID: 9217778)
1. Bayesian interim analysis of randomised trials.
Fayers P
Lancet; 1997 Jun; 349(9069):1911. PubMed ID: 9217778
[No Abstract] [Full Text] [Related]
2. Bayesian interim analysis of randomised trials.
Abrams KR; Jones DR
Lancet; 1997 Jun; 349(9069):1911-2. PubMed ID: 9217779
[No Abstract] [Full Text] [Related]
3. Bayesian interim statistical analysis of randomised trials.
Brophy JM; Joseph L
Lancet; 1997 Apr; 349(9059):1166-8. PubMed ID: 9113025
[No Abstract] [Full Text] [Related]
4. Carcinoma of the esophagus: is biology screaming in my deaf ears?
Ajani JA
J Clin Oncol; 2005 Jul; 23(19):4256-8. PubMed ID: 15781878
[No Abstract] [Full Text] [Related]
5. Bayesian interim analysis of randomised trials.
Hall GH
Lancet; 1997 Jun; 349(9069):1910-1. PubMed ID: 9217777
[No Abstract] [Full Text] [Related]
6. [Multimodal therapy concepts in esophageal carcinoma].
Porschen R; Roth SL; Röher HD; Strohmeyer G
Dtsch Med Wochenschr; 1993 Apr; 118(17):634-40. PubMed ID: 8482241
[No Abstract] [Full Text] [Related]
7. [The effect of local control on overall survival after the breast-conserving therapy of breast carcinoma].
Sauer R
Strahlenther Onkol; 1996 Apr; 172(4):181-5. PubMed ID: 8623079
[TBL] [Abstract][Full Text] [Related]
8. Current status of preoperative treatment for carcinoma of the esophagus.
Naunheim KS
Semin Thorac Cardiovasc Surg; 1992 Oct; 4(4):270-5. PubMed ID: 1457565
[No Abstract] [Full Text] [Related]
9. Tutorial in biostatistics Bayesian data monitoring in clinical trials.
Fayers PM; Ashby D; Parmar MK
Stat Med; 1997 Jun; 16(12):1413-30. PubMed ID: 9232762
[TBL] [Abstract][Full Text] [Related]
10. [The indications for and results of palliative treatment in patients with esophageal and cardial carcinomas].
Peracchia A; Segalin A; Bonavina L
Ann Ital Chir; 1993; 64(6):651-6. PubMed ID: 7521599
[No Abstract] [Full Text] [Related]
11. Choices in treating carcinoma of the esophagus.
Skinner DB
Can J Surg; 1989 Nov; 32(6):420-3. PubMed ID: 2819618
[TBL] [Abstract][Full Text] [Related]
12. Bayesian stopping rules for trials.
Nicholl J; Goodacre S
Lancet; 2002 Jan; 359(9300):76-7. PubMed ID: 11809213
[No Abstract] [Full Text] [Related]
13. Bayesian stopping rules for trials.
Kulvichit K
Lancet; 2002 Jan; 359(9300):77. PubMed ID: 11809215
[No Abstract] [Full Text] [Related]
14. Optimal treatment for localized esophageal cancer still uncertain.
Lord RV
Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
[TBL] [Abstract][Full Text] [Related]
15. Invited commentary.
Hoover EL
Ann Thorac Surg; 2007 Apr; 83(4):1278. PubMed ID: 17383326
[No Abstract] [Full Text] [Related]
16. Invited commentary.
Burfeind W
Ann Thorac Surg; 2007 Apr; 83(4):1264. PubMed ID: 17383323
[No Abstract] [Full Text] [Related]
17. Pre- and postoperative treatment modalities for esophageal squamous cell carcinoma.
Thallinger CM; Kiesewetter B; Raderer M; Hejna M
Anticancer Res; 2012 Nov; 32(11):4609-27. PubMed ID: 23155224
[TBL] [Abstract][Full Text] [Related]
18. [Esophageal carcinoma: non-surgical therapy].
Geissler M; Schwacha H; Eggstein S; Usadel H; Harder J; Opitz O; Arnold C; Grimm CF; Blum HE
Praxis (Bern 1994); 2004 Dec; 93(49):2057-64. PubMed ID: 15630988
[TBL] [Abstract][Full Text] [Related]
19. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
[TBL] [Abstract][Full Text] [Related]
20. Multimodal therapy for esophageal adenocarcinoma.
Badwe RA; Vaidya JS; Bhansali MS
N Engl J Med; 1997 Jan; 336(5):374-5; author reply 375-6. PubMed ID: 9011794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
